Loading...
XNASPDEX
Market cap161mUSD
Jan 08, Last price  
49.70USD
1D
-4.42%
1Q
70.56%
Jan 2017
957.45%
Name

Pro-Dex Inc

Chart & Performance

D1W1MN
XNAS:PDEX chart
P/E
76.16
P/S
3.01
EPS
0.65
Div Yield, %
0.00%
Shrs. gr., 5y
-3.64%
Rev. gr., 5y
14.66%
Revenues
54m
+16.83%
13,834,00017,061,00021,563,00025,126,00021,122,00023,211,00027,109,00017,257,00012,249,00010,812,00013,383,00020,158,00021,943,00022,465,00027,172,00034,834,00038,029,00042,041,00046,087,00053,844,000
Net income
2m
-69.93%
1,849,000827,000506,000317,000-2,845,000-2,968,0002,640,000-876,000-1,784,000-488,000-365,000822,0005,084,0001,621,0004,148,0006,112,0004,450,0004,572,0007,074,0002,127,000
CFO
6m
+13.49%
557,00055,0001,480,0002,018,0001,718,0003,240,0002,898,00045,000-1,271,000-329,000-775,000466,0003,235,0003,096,0003,326,0005,897,000-2,078,000-847,0005,462,0006,199,000
Earnings
Feb 06, 2025

Profile

Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.
URL
https://www.pro-dex.com/
IPO date
May 31, 1994
Employees
134
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
53,844
16.83%
46,087
9.62%
42,041
10.55%
Cost of revenue
46,671
40,325
36,883
Unusual Expense (Income)
NOPBT
7,173
5,762
5,158
NOPBT Margin
13.32%
12.50%
12.27%
Operating Taxes
507
2,354
851
Tax Rate
7.07%
40.85%
16.50%
NOPAT
6,666
3,408
4,307
Net income
2,127
-69.93%
7,074
54.72%
4,572
2.74%
Dividends
Dividend yield
Proceeds from repurchase of equity
(3,505)
(1,547)
(1,546)
BB yield
5.00%
2.23%
2.58%
Debt
Debt current
4,829
4,243
3,285
Long-term debt
9,900
12,603
14,358
Deferred revenue
(8)
(2,131)
Other long-term liabilities
8
544
Net debt
6,318
5,255
14,260
Cash flow
Cash from operating activities
6,199
5,462
(847)
CAPEX
(983)
(974)
(1,671)
Cash from investing activities
(2,233)
(885)
(1,235)
Cash from financing activities
(4,271)
(2,490)
(790)
FCF
6,358
4,193
(2,906)
Balance
Cash
6,848
4,070
1,604
Long term investments
1,563
7,521
1,779
Excess cash
5,719
9,287
1,281
Stockholders' equity
30,867
31,590
23,668
Invested Capital
38,695
36,642
35,845
ROIC
17.70%
9.40%
13.26%
ROCE
16.15%
12.54%
13.14%
EV
Common stock shares outstanding
3,571
3,637
3,763
Price
19.64
2.83%
19.10
19.75%
15.95
-47.81%
Market cap
70,139
0.97%
69,466
15.73%
60,025
-50.10%
EV
76,457
74,721
74,285
EBITDA
8,333
6,619
5,884
EV/EBITDA
9.18
11.29
12.62
Interest
558
533
464
Interest/NOPBT
7.78%
9.25%
9.00%